A GLOBAL COLLABORATION FOR EQUITABLE ACCESS TO BIOTECHNOLOGY
Bench to Bedside: Developing Affordable Diagnostics
Wed 29 July, 14:00-15:00 GMT
Virtual symposium featuring talks on diagnostic devices, from research and development to implementation. Join breakout sessions with researchers from Africa, Asia, Latin America and beyond to continue discussions on quality assurance, device design, and more. Participate to share your experiences and join Reclone Network working groups.
BENCH TO BEDSIDE: DEVELOPING AFFORDABLE DIAGNOSTICS
| Time_(GMT) | Session | Speaker |
|---|---|---|
| 13:45 | Virtual room opens | |
| 14:00 | Opening Remarks | |
| Harnessing African indigenous biological resources to develop “Best-in-Class” biologics for diagnostics. | Daniel Ndima, CapeBio, South Africa | |
| 14:15 | Breakout Sessions | |
| Tools for evaluating the reliability and activity of locally produced enzymes |
Nadine Mowoh, MboaLab, Cameroon | |
| Development of Rapid Diagnostic Tests to Meet the REASSURED Criteria |
Dr Kevin Land, University of Pretoria, South Africa | |
| Travelling hopefully: collecting data to satisfy the Regulators (in my country) |
Dr Keith Moore, Ateneo de Manila University, Philippines | |
| 14:45 | Closing Talk | |
| Designing user-friendly diagnostics | Dr Jacqueline Linnes, Purdue University, USA | |
| 15:00 | Meeting Closes | |
| Online room will be open for continued discussion |
Programme
Daniel Ndima
Daniel Ndima is the CEO of CapeBio in South Africa. CapeBio develops and manufactures molecular biology reagents. Mr Ndima has a Bachelors degree in Biotechnology from the University of the Western Cape, Cape Town, and a Masters degree in Structural Biology from the University of Pretoria. Recently, CapeBio has been working on the development of Covid-19 test kits.
Harnessing African indigenous biological resources to develop “Best-in-Class” biologics for diagnostics.
Africa relies heavily on international imports of Biotech products. The African Biotech Industry can be ignited by existing indigenous biological resources. The un-tapped biological reserves are proving to play a pivotal role in the development of diagnostic tools and reagents. Intra-African Biotech research, IP generation and trade can contribute to global distribution of Biotech technologies emerging from the African continent.
